MYERS ENGINEERING INTERATIONAL INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for MYERS ENGINEERING INTERATIONAL INC

Sort by

Viewing results 1‒20 of 20

Fintech
Tech drives financial sector consultancy in the post-crisis era
...Among clients “there’s been a shift from traditional advisory-based consulting to more engineering-led consulting”, he adds....
January 18, 2018
Gold
Investors Chronicle: Merck, Pearson, GKN
...But the hard work is not yet over for Merck: Bristol-Myers Squibb, AstraZeneca and Roche are all vying for its spot as the leader in lung cancer treatment....
January 19, 2018
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthUS & Canadian companies
Pharma turns to big data to gauge care and pricing
...Andy Schmeltz, who heads the division, gives the example of Eliquis, an anticoagulant produced with Bristol-Myers Squibb....
July 11, 2017
Pharmaceuticals sector
Big pharma turns to small biotechs for edge in cancer treatment
...The early leaders are Merck and Bristol-Myers Squibb....
April 7, 2015
US & Canadian companies
Juno Therapeutics vies for cancer treatment lead
...This involves extracting blood from patients and re-engineering the disease-fighting T-cells in a way that enhances their ability to destroy tumours....
December 17, 2014
The Big Read
Healthcare: Counting the cost of cancer
...Novartis, meanwhile, is leading a different approach that involves extracting white blood cells from patients and re-engineering them in a laboratory....
January 15, 2015
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Pharmaceuticals sector
Drug development: Big pharma back in the game it made
...Novartis is at the forefront of another form of immuno-oncology which involves genetically re-engineering the white blood cells to hunt down and destroy tumours....
September 25, 2014
Pharmaceuticals sector
Battling cancer: Focus turns to defence as best form of attack
...Other approaches are being developed, including some involving the genetic re-engineering of patients’ T-cells to attack cancer....
September 25, 2014
Pharmaceuticals sector
Hopes for cancer cures offer comfort for battered pharma
...Novartis, another big oncology player, is placing its bets on a different form of immunotherapy that involves removing patients’ T-cells from their bodies and re-engineering them to destroy cancer cells...
May 30, 2014
Pharmaceuticals sector
General Electric boosts life sciences division with $1.06bn deal
...Bristol-Myers Squibb, represented by Kirkland and Ellis and Goldman Sachs, agreed to sell its diabetes business to AstraZeneca for $4.1bn....
January 6, 2014
Oil
NOCs: Need for energy is driving force behind global thirst for assets
...Many of the NOCs have “become more nimble in the last decade”, agrees Amy Myers Jaffe, executive director for energy and sustainability at UC Davis Graduate School of Management....
October 7, 2012
Markets InsightUS healthcare reform
Pharma’s fall from grace presents a buying opportunity
...When I look round the market I see that we do price in scientific advances in areas such as electronics and engineering. But not in the biological sciences. There is a tremendous amount going on....
July 11, 2011
European companies
Europeans fear US fever could be contagious
...This is apparent in our standard products business in Germany,” said Peter Löscher, chief executive of Siemens, Europe’s largest engineering group....
May 1, 2008
Aerospace & Defence
Bowman to take helm at Smiths
...The sacking – which Coles Myer claimed was due to the leaking of confidential information – sent Mr Bowman into the courts, where he won about £907,000 in compensation....
September 25, 2007
LexPrivate equity
Coles Myer
...Aside from financial engineering, there is scope to improve performance. Coles Myer trails the bigger Woolworths on a raft of measures, including operating margins and quarterly sales growth....
August 18, 2006
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
Asia-Pacific equities
Growth in Asia-Pacific deals reaches new highs
...Carlyle bid $6.5bn for Advanced Semiconductor Engineering while MBK Partners, a Seoul-based start-up, burst on to the scene with a $1.5bn buy-out of China Network Systems....
December 26, 2006
Mergers & Acquisitions
Monoclonal antibodies: Magic bullets close in on target
...Rituxan from Roche, Genentech and Biogen Idec, used to treat non-Hodgkin’s lymphoma, and Erbitux from ImClone and Bristol-Myers Squibb, to treat colorectal cancer, are other very successful MAb cancer drugs...
October 18, 2005
News in-depthOil
A new Asian invasion
...“If there is some uncertainty about getting approval and how long it will take, then a seller has to take that into account,” said says Kurt Berney, a n M&A partner with O’Melveny and Myers, the a law firm...
June 23, 2005
Asia-Pacific equities
Seoul shares boosted by surprise rate cut
...Coles Myer, the retailer, fell 2.2 per cent to A$8.80 as the market brushed aside an upgrade to its annual earnings forecast....
August 12, 2004
Asia-Pacific equities
Asian tech stocks stay on upward track
...Coles Myer, Australia's biggest retailer, rose 1 per cent to a record high of A$9.59, while supermarket group Woolworths hit a new high of A$13.80 before falling back and finishing 0.7 per cent lower at...
September 14, 2004

Previous pagePage 1 of 1Next page